ASK REDCHAT ANYTHING ABOUT TSCAN THERAPEUTICS INC.
TScan Therapeutics Inc. (NASDAQ: TCRX)
Listen to this Section
$0.88
+0.0001
(
+0.01% )
0.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| TSC-100 & TSC-101DetailsCancer, Hematologic malignancies |
Phase 1 |
| TSC-203-A0201, TSC-200-A0201, TSC-204-A0201, TSC-204-C0702,TSC-201-B0702, TSC-204-A0101DetailsCancer, Solid tumor/s, Human papillomavirus |
Phase 1 |
Market Data
|
| Open |
$0.88 |
| Previous Close |
$0.88 |
| Volume |
0.0K |
| Market Cap |
$57.57M |
| Day Range |
$0.92 - $0.92 |
| 52 Week Range |
$0.85 - $2.57 |
| Shares Outstanding |
65.35M |
| Change % |
+0.01% |
| Net Change |
▲ 0.0001 |
| Insider Ownership |
0.00% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2021 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
5,858,839.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-06-14 |
Sale |
-47500.00 |
BAKER BROS. ADVISORS LP |
| 2024-05-03 |
Sale |
-380000.00 |
Louis Chrystal |
| 2024-04-23 |
Buy |
825968.00 |
BAKER BROS. ADVISORS LP |
| 2024-04-23 |
Buy |
5000000.00 |
Lynx1 Capital Management LP |
| 2024-02-02 |
Sale |
-750000.00 |
Amello Jason |
| 2023-12-21 |
Buy |
28830.00 |
BARBERICH TIMOTHY J |
| 2023-12-18 |
Buy |
5000.00 |
Klencke Barbara |
| 2023-12-08 |
Sale |
-17500.00 |
Woods Keith |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 10-q |
Quarterly Reports |
53 |
Nov 12, 2025 |
| 8-k |
8K-related |
12 |
Nov 12, 2025 |
| 8-k |
8K-related |
19 |
Nov 03, 2025 |
| 8-k |
8K-related |
53 |
Sep 09, 2025 |
| 3 |
Insider transactions |
2 |
Aug 22, 2025 |
| 8-k |
8K-related |
12 |
Aug 20, 2025 |
| 8-k |
8K-related |
12 |
Aug 12, 2025 |
| 10-q |
Quarterly Reports |
52 |
Aug 12, 2025 |
| 4 |
Insider transactions |
2 |
Jul 02, 2025 |
| 4 |
Insider transactions |
1 |
Jul 02, 2025 |